Eton Pharmaceuticals Inc (NASDAQ: ETON) on Friday, soared 12.32% from the previous trading day, before settling in for the closing price of $15.26. Within the past 52 weeks, ETON’s price has moved between $3.40 and $21.48.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 32.22% over the past five years. The company achieved an average annual earnings per share of 215.56%. With a float of $22.93 million, this company’s outstanding shares have now reached $26.82 million.
Let’s look at the performance matrix of the company that is accounted for 31 employees. In terms of profitability, gross margin is 58.49%, operating margin of -4.69%, and the pretax margin is -9.3%.
Eton Pharmaceuticals Inc (ETON) Insider Updates
Observing investor behavior towards Drug Manufacturers – Specialty & Generic industry stocks is more important than anything else. The insider ownership of Eton Pharmaceuticals Inc is 14.51%, while institutional ownership is 54.80%. The most recent insider transaction that took place on Jun 12 ’25, was worth 253,297. In this transaction Chief Business Officer of this company sold 16,977 shares at a rate of $14.92, taking the stock ownership to the 629,669 shares. Before that another transaction happened on Jun 16 ’25, when Company’s Chief Business Officer sold 10,223 for $14.73, making the entire transaction worth $150,585. This insider now owns 612,646 shares in total.
Eton Pharmaceuticals Inc (ETON) Performance Highlights and Predictions
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported 0.02 earnings per share (EPS) for the period topping the consensus outlook (set at -0.01) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.19 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 215.56% per share during the next fiscal year.
Eton Pharmaceuticals Inc (NASDAQ: ETON) Trading Performance Indicators
Eton Pharmaceuticals Inc (ETON) is currently performing well based on its current performance indicators. A quick ratio of 1.16 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.90. Likewise, its price to free cash flow for the trailing twelve months is 37.61.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.15, a number that is poised to hit 0.09 in the next quarter and is forecasted to reach 1.03 in one year’s time.
Technical Analysis of Eton Pharmaceuticals Inc (ETON)
Eton Pharmaceuticals Inc (NASDAQ: ETON) saw its 5-day average volume 0.46 million, a positive change from its year-to-date volume of 0.37 million. As of the previous 9 days, the stock’s Stochastic %D was 87.65%.
During the past 100 days, Eton Pharmaceuticals Inc’s (ETON) raw stochastic average was set at 58.24%, which indicates a significant decrease from 98.25% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.88 in the past 14 days, which was lower than the 1.00 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $15.06, while its 200-day Moving Average is $14.22. Nevertheless, the first resistance level for the watch stands at $17.98 in the near term. At $18.83, the stock is likely to face the second major resistance level. The third major resistance level sits at $20.45. If the price goes on to break the first support level at $15.51, it is likely to go to the next support level at $13.89. Assuming the price breaks the second support level, the third support level stands at $13.04.
Eton Pharmaceuticals Inc (NASDAQ: ETON) Key Stats
Market capitalization of the company is 459.65 million based on 26,818K outstanding shares. Right now, sales total 39,010 K and income totals -3,820 K. The company made 17,280 K in profit during its latest quarter, and -1,570 K in sales during its previous quarter.
